Kim Kelderman insider trades

Open-market stock purchases and sales by Kim Kelderman, Director at CONMED Corp, from SEC Form 4 filings since May 1, 2018.

Recent trades

DateStockTradeValue
Sep 8, 2026CNMD CONMED CorpBought (not open market)—
Jun 1, 2026CNMD CONMED CorpBought (not open market)—
May 5, 2026TECH BIO-TECHNE CorpSold (not open market)$1.4M
May 5, 2026TECH BIO-TECHNE CorpBought (not open market)—
Apr 22, 2026TECH BIO-TECHNE CorpSold (not open market)$79.8K
Apr 22, 2026TECH BIO-TECHNE CorpBought (not open market)—
Apr 14, 2026TECH BIO-TECHNE CorpSold (not open market)$1.9M
Apr 14, 2026TECH BIO-TECHNE CorpBought (not open market)—
Nov 3, 2025TECH BIO-TECHNE CorpSold (not open market)$144K

Companies traded

  • CNMD CONMED Corp: other filings, last Sep 8, 2026
  • TECH BIO-TECHNE Corp: 8 sales, last May 5, 2026

Get free alerts when Kim Kelderman files a new trade →